Repeated Sulforaphane Treatment Reverses Depressive-like Behavior and Exerts Antioxidant Effects in the Olfactory Bulbectomy Model in Mice

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2024 Jun 27

PMID 38931429

Authors

Patrycja Panczyszyn-Trzewik

Katarzyna Stachowicz

Paulina Misztak

Gabriel Nowak

Magdalena Sowa-Kucma

Affiliations

Soon will be listed here.

Abstract

Growing evidence suggests that activators of nuclear factor erythroid-derived 2-like 2 (Nrf2), such as sulforaphane, may represent promising novel pharmacological targets for conditions related to oxidative stress, including depressive disorder. Therefore, we conducted a study to explore the behavioral and biochemical effects of repeated (14 days) sulforaphane (SFN) treatment in the olfactory bulbectomy (OB) animal model of depression. An open field test (OFT), splash test (ST), and spontaneous locomotor activity test (LA) were used to assess changes in depressive-like behavior and the potential antidepressant-like activity of SFN. The OB model induced hyperactivity in mice during the OFT and LA as well as a temporary loss of self-care and motivation in the ST. The repeated administration of SFN (10 mg/kg) effectively reversed these behavioral changes in OB mice across all tests. Additionally, a biochemical analysis revealed that SFN (10 mg/kg) increased the total antioxidant capacity in the frontal cortex and serum of the OB model. Furthermore, SFN (10 mg/kg) significantly enhanced superoxide dismutase activity in the serum of OB mice. Overall, the present study is the first to demonstrate the antidepressant-like effects of repeated SFN (10 mg/kg) treatment in the OB model and indicates that these benefits may be linked to improved oxidative status.

References

Silvestrini A, Meucci E, Ricerca B, Mancini A . Total Antioxidant Capacity: Biochemical Aspects and Clinical Significance. Int J Mol Sci. 2023; 24(13). PMC: 10341416. DOI: 10.3390/ijms241310978. View

Ferreira-Chamorro P, Redondo A, Riego G, Leanez S, Pol O . Sulforaphane Inhibited the Nociceptive Responses, Anxiety- and Depressive-Like Behaviors Associated With Neuropathic Pain and Improved the Anti-allodynic Effects of Morphine in Mice. Front Pharmacol. 2018; 9:1332. PMC: 6277937. DOI: 10.3389/fphar.2018.01332. View

Zhang J, Yao W, Dong C, Yang C, Ren Q, Ma M . Corrigendum to "Prophylactic Effects of Sulforaphane on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation" Journal of Nutritional Biochemistry 39 (2017) 134-144. J Nutr Biochem. 2020; 88:108550. DOI: 10.1016/j.jnutbio.2020.108550. View

Bhandari R, Kaur J, Kaur S, Kuhad A . The Nrf2 pathway in psychiatric disorders: pathophysiological role and potential targeting. Expert Opin Ther Targets. 2021; 25(2):115-139. DOI: 10.1080/14728222.2021.1887141. View

Chang C, Lee C, Lan T, Ju P, Hsieh Y, Lai T . Effects of antidepressant treatment on total antioxidant capacity and free radical levels in patients with major depressive disorder. Psychiatry Res. 2015; 230(2):575-80. DOI: 10.1016/j.psychres.2015.10.006. View

Siwek M, Sowa-Kucma M, Styczen K, Misztak P, Szewczyk B, Topor-Madry R . Thiobarbituric Acid-Reactive Substances: Markers of an Acute Episode and a Late Stage of Bipolar Disorder. Neuropsychobiology. 2016; 73(2):116-22. DOI: 10.1159/000444491. View

Yao W, Zhang J, Ishima T, Dong C, Yang C, Ren Q . Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice. Sci Rep. 2016; 6:30659. PMC: 4965765. DOI: 10.1038/srep30659. View

Kielan A, Jaworski M, Mosiolek A, Chodkiewicz J, Swiecicki L, Walewska-Zielecka B . Factors Related to the Level of Depression and Suicidal Behavior Among Men With Diagnosed Depression, Physically Ill Men, and Healthy Men. Front Psychiatry. 2021; 12:644097. PMC: 8260949. DOI: 10.3389/fpsyt.2021.644097. View

Solberg B, Halmoy A, Engeland A, Igland J, Haavik J, Klungsoyr K . Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder. Acta Psychiatr Scand. 2017; 137(3):176-186. PMC: 5838558. DOI: 10.1111/acps.12845. View

10.

de Almeida R, Ganzella M, Machado D, Loureiro S, Leffa D, Quincozes-Santos A . Olfactory bulbectomy in mice triggers transient and long-lasting behavioral impairments and biochemical hippocampal disturbances. Prog Neuropsychopharmacol Biol Psychiatry. 2017; 76:1-11. DOI: 10.1016/j.pnpbp.2017.02.013. View

11.

Machado D, Cunha M, Neis V, Balen G, Colla A, Grando J . Fluoxetine reverses depressive-like behaviors and increases hippocampal acetylcholinesterase activity induced by olfactory bulbectomy. Pharmacol Biochem Behav. 2012; 103(2):220-9. DOI: 10.1016/j.pbb.2012.08.024. View

12.

Holzmann I, da Silva L, da Silva J, Steimbach V, de Souza M . Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways. Pharmacol Biochem Behav. 2015; 136:55-63. DOI: 10.1016/j.pbb.2015.07.003. View

13.

Sun Y, Yang T, Mao L, Zhang F . Sulforaphane Protects against Brain Diseases: Roles of Cytoprotective Enzymes. Austin J Cerebrovasc Dis Stroke. 2018; 4(1). PMC: 5880051. DOI: 10.26420/austinjcerebrovascdisstroke.2017.1054. View

14.

Sowa-Kucma M, Styczen K, Siwek M, Misztak P, Nowak R, Dudek D . Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts. Prog Neuropsychopharmacol Biol Psychiatry. 2017; 81:372-383. DOI: 10.1016/j.pnpbp.2017.08.024. View

15.

Kraeuter A, Guest P, Sarnyai Z . The Open Field Test for Measuring Locomotor Activity and Anxiety-Like Behavior. Methods Mol Biol. 2018; 1916:99-103. DOI: 10.1007/978-1-4939-8994-2_9. View

16.

Ait Tayeb A, Poinsignon V, Chappell K, Bouligand J, Becquemont L, Verstuyft C . Major Depressive Disorder and Oxidative Stress: A Review of Peripheral and Genetic Biomarkers According to Clinical Characteristics and Disease Stages. Antioxidants (Basel). 2023; 12(4). PMC: 10135827. DOI: 10.3390/antiox12040942. View

17.

Martin-Hernandez D, Caso J, Meana J, Callado L, Madrigal J, Garcia-Bueno B . Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants. J Neuroinflammation. 2018; 15(1):251. PMC: 6122627. DOI: 10.1186/s12974-018-1294-2. View

18.

Mohammadzadeh M, Halabian R, Gharehbaghian A, Amirizadeh N, Jahanian-Najafabadi A, Roushandeh A . Nrf-2 overexpression in mesenchymal stem cells reduces oxidative stress-induced apoptosis and cytotoxicity. Cell Stress Chaperones. 2012; 17(5):553-65. PMC: 3535169. DOI: 10.1007/s12192-012-0331-9. View

19.

Wu S, Gao Q, Zhao P, Gao Y, Xi Y, Wang X . Sulforaphane produces antidepressant- and anxiolytic-like effects in adult mice. Behav Brain Res. 2016; 301:55-62. DOI: 10.1016/j.bbr.2015.12.030. View

20.

Dai X, Yan X, Wintergerst K, Cai L, Keller B, Tan Y . Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function. Trends Mol Med. 2019; 26(2):185-200. DOI: 10.1016/j.molmed.2019.09.007. View